Cryptococcus genome variation over the course of drug treatment. Cryptococcus sp. (in: basidiomycete fungi)

This sub-study of the Ambition-CM trial collected serial time points and multiple isolates per sample over the first 14 days of antifungal therapy to evaluate the contribution of pathogen genotype to clinical outcomes.